{"organizations": [], "uuid": "d50b5b92da5cb0a27693af3b7568efa556d41ee1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/2", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/04/18/pr-newswire-vanda-pharmaceuticals-to-announce-first-quarter-2018-financial-results-on-may-2-2018.html", "country": "US", "domain_rank": 767, "title": "Vanda Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 2, 2018", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.012, "site_type": "news", "published": "2018-04-19T00:30:00.000+03:00", "replies_count": 0, "uuid": "d50b5b92da5cb0a27693af3b7568efa556d41ee1"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/04/18/pr-newswire-vanda-pharmaceuticals-to-announce-first-quarter-2018-financial-results-on-may-2-2018.html", "ord_in_thread": 0, "title": "Vanda Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 2, 2018", "locations": [], "entities": {"persons": [{"name": "vanda", "sentiment": "negative"}, {"name": "vanda pharmaceutica", "sentiment": "none"}], "locations": [{"name": "washington", "sentiment": "none"}], "organizations": [{"name": "vanda pharmaceuticals inc.", "sentiment": "negative"}, {"name": "vanda pharmaceuticals", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WASHINGTON, Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will release results for the first quarter of 2018 on Wednesday, May 2, 2018, after the market closes.\nVanda will host a conference call at 4:30 PM ET on Wednesday, May 2, 2018, during which management will discuss the first quarter 2018 financial results and other corporate activities. To participate in the conference call, please dial 1-888-771-4371 (domestic) or 1-847-585-4405 (international) and use passcode 46823596.\nThe conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com . Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.\nA replay of the call will be available on Wednesday, May 2, 2018, beginning at 7:00 PM ET and will be accessible until Wednesday, May 9, 2018, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 46823596.\nABOUT VANDA PHARMACEUTICALS INC.:\nVanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com .\nInvestor Contact:\nJim Kelly\nExecutive Vice President & Chief Financial Officer\nVanda Pharmaceuticals Inc.\n(202) 734-3428\njim.kelly@vandapharma.com\n releases/vanda-pharmaceuticals-to-announce-first-quarter-2018-financial-results-on-may-2-2018-300632344.html\nSOURCE Vanda Pharmaceuticals Inc.", "external_links": ["http://www.vandapharma.com/", "http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2018-financial-results-on-may-2-2018-300632344.html"], "published": "2018-04-19T00:30:00.000+03:00", "crawled": "2018-04-19T02:35:18.014+03:00", "highlightTitle": ""}